BioCentury
ARTICLE | Company News

Calydon, Cell Genesys deal

September 10, 2001 7:00 AM UTC

CEGE completed its acquisition of private cancer company Calydon for 935,000 CEGE shares valued at $17 million based on CEGE's Friday close at $18.20 (see BioCentury, Aug. 6). ...